{"id":"NCT00156910","sponsor":"Allergan","briefTitle":"A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-02","primaryCompletion":"2007-11","completion":"2008-07","firstPosted":"2005-09-12","resultsPosted":"2010-12-07","lastUpdate":"2013-11-18"},"enrollment":679,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Migraine Disorders"],"interventions":[{"type":"BIOLOGICAL","name":"Botulinum Toxin Type A","otherNames":["BOTOXÂ®"]},{"type":"OTHER","name":"Placebo (saline)","otherNames":[]}],"arms":[{"label":"botulinum toxin Type A","type":"EXPERIMENTAL"},{"label":"Placebo (saline)","type":"PLACEBO_COMPARATOR"}],"summary":"This is a 60 week study including a double-blind phase followed by an open-label extension phase.","primaryOutcome":{"measure":"Change in Frequency of Headache Episodes","timeFrame":"Baseline, Week 24","effectByArm":[{"arm":"Botulinum Toxin Type A","deltaMin":12.3,"sd":5.23},{"arm":"Placebo (Saline)","deltaMin":13.4,"sd":5.71}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":9},"locations":{"siteCount":2,"countries":["United States","Canada"]},"refs":{"pmids":["33026631","33026630","31112399","25500317","25080874","21883197","20487038"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":42,"n":624},"commonTop":["Neck pain","Sinusitis","Upper respiratory tract infection","Nasopharyngitis","Muscular weakness"]}}